 YARDLEY, Pa., Dec. 01, 2020 GLOBE NEWSWIRE -- Optinose NASDAQ:OPTN, a pharmaceutical company focused on patients treated by ear, nose and throat ENT and allergy specialists, today announced its Board of Directors has named Tomas J. Heyman as a new director. 